Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

The new CEO has at least five years and a large M&A war chest to position Sanofi for life after the loss of exclusivity on its cornerstone immunology product. Belén Garijo takes over as Sanofi CEO ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

European drug regulators have given a positive review to an experimental multiple sclerosis treatment from Sanofi that the Food and Drug Administration rejected earlier this year, positioning the ...

Hello, everyone. This is Thomas Larsen from the Sanofi IR team. Welcome to the First Quarter 2026 conference call for investors and analysts. As usual, you will find the slides on sanofi.com. Please ...

Normally on Big Pharma earnings calls, execs are eager to talk up their new launches and tout blockbuster expectations. But during Sanofi’s first-quarter presentation, a patent defense took center ...

Sanofi reported better-than-expected profit in a boost for incoming Chief Executive Officer Belén Garijo as she confronts the challenge of rejuvenating the drugmaker’s pipeline of new medicines.

France’s Sanofi SAN-0.87%decrease; red down pointing triangle booked an increase in sales for the first quarter, boosted by new launches and recent acquisitions at a time when the group undergoes a ...

As Sanofi counts down the days before its new leader arrives, the French pharma’s chief financial officer acknowledged there had been a “certain number of setbacks” under Paul Hudson’s tenure. When ...

LONDON, April 23 (Reuters) - Sanofi (SASY.PA), opens new tab beat first-quarter estimates on Thursday as demand for ‌its asthma and eczema drug Dupixent remained high, though analysts looked to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Sanofi's new chief executive, Belén Garijo, will see her tenure at the company kick-started by a strong 2026 first quarter, with a healthy rise in revenues driven by immunology blockbuster Dupixent ...